Sugi Predict

Sugi Predict / Compounds / SCHEMBL11948601

SCHEMBL11948601

SCHEMBL11948601

CCOC(=O)c1cn([C@H](CO[Si](C)(C)C(C)(C)C)C(C)(C)C)c2ccc(Cc3cccc(Cl)c3F)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 2/20 0.35
▸ P2RX3 P56373 1/20 0.34
▸ NR3C2 P08235 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ PDE3B Q13370 2/20 0.33
▸ PDE3A Q14432 2/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MRGPRX4 Q96LA9 1/20 0.33
▸ GAPDH P04406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16850598 1.00 METTL3 (0.42) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL12931142 0.90 KMT2A (0.36) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL16850612 0.90 METTL3 (0.47) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL11948616 0.90 METTL3 (0.47) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL11948625 0.87 METTL3 (0.39) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL15082536 0.87 METTL3 (0.39) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL11948611 0.87 METTL3 (0.51) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL16850605 0.87 METTL3 (0.51) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL11956958 0.86 METTL3 (0.43) METTL3ALDH1A1LMNAMAPTKMT2A
SCHEMBL16854885 0.86 METTL3 (0.43) METTL3ALDH1A1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130172344-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR JAPAN TOBACCO INC. 2013-07-04 — — US disclosed
US-8232401-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2012-07-31 — — US disclosed
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
US-7176220-B2 4-oxoquinoline compound and use thereof as pharmaceutical agent JAPAN TOBACCO INC. (JP) 2007-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172344-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR IMPDH1, CDKL4, IMPDH2 METTL3 1861/4885ALDH1A1 703/4885LMNA 2495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.